Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-alpha-phellandrene | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of AP3M2 mRNA | CTD | PMID:25075043 | 1,2,4-trimethylbenzene | decreases expression | EXP | | 6480464 | pseudocumene results in decreased expression of AP3M2 protein | CTD | PMID:17337753 | 1,2-dimethylhydrazine | increases expression | ISO | Ap3m2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of AP3M2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of AP3M2 mRNA | CTD | PMID:20660070 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ap3m2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of AP3M2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AP3M2 mRNA | CTD | PMID:33387578 | 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of AP3M2 mRNA | CTD | PMID:19643169 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AP3M2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AP3M2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Ap3m2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of AP3M2 exon and bisphenol S affects the methylation of AP3M2 gene | CTD | PMID:31683443 and PMID:33297965 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Ap3m2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of AP3M2 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | affects expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Decitabine affects the expression of AP3M2 mRNA | CTD | PMID:23300844 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of AP3M2 mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of AP3M2 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | Ap3m2 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of AP3M2 mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of AP3M2 mRNA | CTD | PMID:22100608 | all-trans-retinoic acid | decreases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of AP3M2 mRNA | CTD | PMID:33167477 | alpha-phellandrene | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of AP3M2 mRNA | CTD | PMID:25075043 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of AP3M2 mRNA | CTD | PMID:16483693 | benzene | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Benzene results in increased expression of AP3M2 mRNA | CTD | PMID:19162166 | benzo[a]pyrene | increases expression | ISO | Ap3m2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of AP3M2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of AP3M2 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | ISO | AP3M2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of AP3M2 promoter | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of AP3M2 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of AP3M2 gene | CTD | PMID:31601247 | carbon nanotube | decreases expression | ISO | Ap3m2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | ISO | Ap3m2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of AP3M2 more ... | CTD | PMID:20938992 | cisplatin | affects expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Cisplatin affects the expression of AP3M2 mRNA | CTD | PMID:23300844 | cisplatin | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of AP3M2 mRNA | CTD | PMID:27392435 and PMID:27594783 | cisplatin | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of AP3M2 mRNA | CTD | PMID:27392435 | cyclosporin A | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of AP3M2 mRNA | CTD | PMID:20106945 | cyclosporin A | increases methylation | ISO | AP3M2 (Homo sapiens) | 6480464 | Cyclosporine results in increased methylation of AP3M2 promoter | CTD | PMID:27989131 | dexamethasone | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AP3M2 mRNA | CTD | PMID:28628672 | diethyl maleate | decreases expression | EXP | | 6480464 | diethyl maleate results in decreased expression of AP3M2 mRNA | CTD | PMID:21161181 | dorsomorphin | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AP3M2 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | decreases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of AP3M2 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | Ap3m2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of AP3M2 more ... | CTD | PMID:20938992 | folic acid | decreases expression | ISO | Ap3m2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of AP3M2 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of AP3M2 gene | CTD | PMID:31601247 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of AP3M2 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of AP3M2 mRNA | CTD | PMID:28628672 | L-methionine | multiple interactions | ISO | Ap3m2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of AP3M2 more ... | CTD | PMID:20938992 | methyl methanesulfonate | decreases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of AP3M2 mRNA | CTD | PMID:23649840 | nickel atom | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Nickel results in increased expression of AP3M2 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | decreases expression | EXP | | 6480464 | Ozone results in decreased expression of AP3M2 mRNA | CTD | PMID:28623178 | paracetamol | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of AP3M2 mRNA | CTD | PMID:26690555 and PMID:29067470 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of AP3M2 mRNA | CTD | PMID:33387578 | progesterone | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of AP3M2 mRNA | CTD | PMID:20660070 | quercetin | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of AP3M2 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AP3M2 mRNA | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of AP3M2 mRNA | CTD | PMID:17879257 | sunitinib | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of AP3M2 mRNA | CTD | PMID:31533062 | tunicamycin | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of AP3M2 mRNA | CTD | PMID:29453283 | undecane | decreases expression | EXP | | 6480464 | undecane results in decreased expression of AP3M2 protein | CTD | PMID:17337753 | valproic acid | increases expression | ISO | Ap3m2 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of AP3M2 mRNA | CTD | PMID:21427059 | valproic acid | multiple interactions | ISO | AP3M2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AP3M2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | AP3M2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of AP3M2 mRNA | CTD | PMID:26272509 and PMID:29154799 | valproic acid | decreases methylation | ISO | AP3M2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of AP3M2 gene | CTD | PMID:29154799 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of AP3M2 mRNA | CTD | PMID:23555832 | |